These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6193314)

  • 1. [A method of determining the fibrinolytic activity of the sputum and lavage fluid].
    Kaminskaia GO; Zhukova NL; Stepanian IE; Lovacheva OV
    Lab Delo; 1983; (6):20-2. PubMed ID: 6193314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on acid mucopolysaccharides of the sputum in chronic obstructive lung diseases].
    Kasama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1974 Jun; 12(6):310-9. PubMed ID: 4279307
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quantification of IgA and lysozyme proteins in sputum from patients with chronic obstructive pulmonary disease. I. Relation of the proteins to sputum viscosity].
    Oteo Ochoa LA; Díaz Enríquez M; Cruz Ramos JL; Martín Serrano C; Sueiro Bendito A
    Rev Clin Esp; 1984 Feb; 172(3):137-40. PubMed ID: 6718785
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease.
    Harbitz O; Jenssen AO; Smidsrød O
    Eur J Respir Dis; 1984 Oct; 65(7):512-20. PubMed ID: 6489486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viscometric and chemical characterization of sputum from patients with chronic obstructive lung disease.
    Jenssen AO; Harbitz O; Smidsrød O
    Scand J Respir Dis; 1978 Jun; 59(3):141-53. PubMed ID: 28562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Concentration of histamine in the sputum of patients with chronic obstructive lung diseases and chronic pulmonary tuberculosis].
    Jakupi M; Mandura I; Kastrati B; Haxhiu MA
    Plucne Bolesti Tuberk; 1983; 35(1-4):103-7. PubMed ID: 6657791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of proteins in the soluble phase of sputum in unstable and stabilization clinical periods in patients with chronic obstructive pulmonary disease. I].
    Oteo Ochoa LA; Sueiro Bendito A
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):279-83. PubMed ID: 6208579
    [No Abstract]   [Full Text] [Related]  

  • 8. Sputum albumin in obstructive airways.
    Persson CG
    Am Rev Respir Dis; 1988 Dec; 138(6):1646-7. PubMed ID: 3202516
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the fibrinolytic activity of the sputum in tubercular patients with hemoptysis and pulmonary hemorrhage].
    Neverov GS
    Probl Tuberk; 1967; 45(8):75-8. PubMed ID: 5606126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Soluble proteins in the sputum of patients with bronchiectases and chronic air-flow restriction].
    Oteo Ochoa LA; Matíes Prats M; de la Cruz Ríos JL; Izquierdo del Amo A; Sueiro Bendito A
    Rev Clin Esp; 1983 Dec; 171(5):321-3. PubMed ID: 6669760
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of the fucose and sialic acid in mucoid sputum from patients with chronic obstructive pulmonary disease].
    Yasuoka S; Nakanishi Y; Doi H; Kawano T; Fujisawa K; Noda Y; Ozaki T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Jul; 24(7):735-41. PubMed ID: 3784171
    [No Abstract]   [Full Text] [Related]  

  • 12. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease.
    Agarwal S; Joyner KA; Swaim MW
    Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of fibrinogen and fibrinolytic activity of the blood in lung cancer, chronic non-specific pneumonia and exudative pleuritis].
    Voprontsova GV
    Sov Med; 1967 May; 30(5):14-7. PubMed ID: 5612340
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunochemical demonstration of fibrogenic subtances in the sputum].
    Tomásová H; Copová M
    Cesk Pediatr; 1968 Dec; 23(12):1094-5. PubMed ID: 5706998
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical applications of wet-mount sputum preparations.
    Hodgkin JE
    West J Med; 1979 Jul; 131(1):48-9. PubMed ID: 483793
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histamine content of the sputa of patients with chronic obstructive bronchitis].
    Zimmermann I; Bugalho de Almeida AA; Park SH; Ulmer WT
    Respiration; 1982; 43(3):194-207. PubMed ID: 7111866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulation and fibrinolysis systems in bronchoalveolar lavage fluid in irradiated lung of rabbits].
    Sawada M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1515-21. PubMed ID: 8121087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibacterial chemotherapy in the management of chronic bronchial obstructive disease.
    Gialdroni-Grassi G
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):431-6. PubMed ID: 7203719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.